The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 15 May 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 158K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labéta, M. O.
Right arrow Articles by Schiffrin, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labéta, M. O.
Right arrow Articles by Schiffrin, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2000/5/1807/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 10, May 15, 2000 1807-1812


Brief Definitive Report

Innate Recognition of Bacteria in Human Milk Is Mediated by a Milk-Derived Highly Expressed Pattern Recognition Receptor, Soluble Cd14

Mario O. Labétaa, Karine Vidalc, Julia E. Rey Noresa, Mauricio Ariasa, Natalio Vitad, B. Paul Morganb, Jean Claude Guillemotd, Denis Loyauxd, Pascual Ferrarad, Daniel Schmidc, Michael Affolterc, Leszek K. Borysiewicza, Anne Donnet-Hughesc, and Eduardo J. Schiffrinc

a Department of Medicine, University of Wales, College of Medicine, Heath Park, Cardiff CF4 4XX, United Kingdom
b Department of Medical Biochemistry, University of Wales, College of Medicine, Heath Park, Cardiff CF4 4XX, United Kingdom
c Nestlé Research Center, Vers-Chez-Les-Blanc, CH-1000 Lausanne 26, Switzerland
d Sanofi-Synthelabo, 31676 Labège Cedex, France
Nestlé Research Center, Vers-Chez-Les-Blanc, CH 1000 Lausanne 26, Switzerland.41-21-785-892541-21-785-8671

eduardo.schiffrin{at}rdls.nestle.com

Little is known about innate immunity to bacteria after birth in the hitherto sterile fetal intestine. Breast-feeding has long been associated with a lower incidence of gastrointestinal infections and inflammatory and allergic diseases. We found in human breast milk a 48-kD polypeptide, which we confirmed by mass spectrometry and sequencing to be a soluble form of the bacterial pattern recognition receptor CD14 (sCD14). Milk sCD14 (m-sCD14) concentrations were up to 20-fold higher than serum sCD14 from nonpregnant, pregnant, or lactating women. In contrast, lipopolysaccharide (LPS)-binding protein was at very low levels. Mammary epithelial cells produced 48-kD sCD14. m-sCD14 mediated activation by LPS and whole bacteria of CD14 negative cells, including intestinal epithelial cells, resulting in release of innate immune response molecules. m-sCD14 was undetectable in the infant formulas and commercial (cows') milk tested, although it was present in bovine colostrum. These findings indicate a sentinel role for sCD14 in human milk during bacterial colonization of the gut, and suggest that m-sCD14 may be involved in modulating local innate and adaptive immune responses, thus controlling homeostasis in the neonatal intestine.

Key Words: innate immunity • neonatal immunity • mucosal immunity • intestinal immune response • breast-feeding


© 2000 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS